Oculis Holding AG
OCS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $322.0M in total; no superinvestor holds it.
Other share classesOCSAW
Q1 2025 vs. Q4 2024
How the institutions holding Oculis Holding AG changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 12 | 20 | +8 |
| Shares | 3.49M | 4.98M | +1.48M (+42.5%) |
| Value | $59.4M | $94.7M | +$35.4M (+59.6%) |
New holders (10)
Institutions that held Oculis Holding AG at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sr One Capital Management, LP | 322,500 | $6.14M | 1.58% |
| Alyeska Investment Group, L.P. | 131,332 | $2.50M | 0.01% |
| Acuta Capital Partners, LLC | 125,000 | $2.38M | 2.76% |
| Kestra Private Wealth Services, LLC | 12,322 | $234.5K | 0.00% |
| State Street Corp | 11,959 | $227.6K | 0.00% |
| Morgan Stanley | 5,116 | $97.4K | 0.00% |
| JPMorgan Chase & Co | 600 | $11.4K | 0.00% |
| Wolverine Asset Management LLC | 399 | $7.59K | 0.00% |
| Tower Research Capital LLC (TRC) | 26 | $495 | 0.00% |
| SBI Securities Co., Ltd. | 4 | $76 | 0.00% |
Sold out (2)
Institutions that held Oculis Holding AG at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 22,911 | $389.3K |
| XTX Topco Ltd | 13,249 | $225.1K |